The LacCOVID study has shown that milk from lactating women who have been vaccinated with Pfizer-BioNTech contains specific antibodies against the SARS-CoV-2 coronavirus
Description of the Study:
- Title: Quantification of specific antibodies against SARS-CoV-2 in breast milk of lactating women vaccinated with an mRNA vaccine.
- Principal Investigators: Erika Esteve Palau and Vicens Díaz de Brito.
- Co-investigators: Araceli Gonzalez Cuevas, M. Eugenia Guerrero, Clara Garcia Terol, M. Carmen Alvarez, Geneva Garcia Aranda and David Casadevall.
- Centres of Implementation: Parc Sanitari Sant Joan de Déu.
- Study Population: 32 lactating women aged over 18 who were vaccinated against SARS-CoV-2 with the Pfizer-BioNTech® COVID-19 vaccine (BNT162b2)
- Study Type: Prospective study.
- Design: Paired serum and breast milk samples were simultaneously taken from each participant at three timepoints after receiving the vaccine:
– 2 weeks after 1st dose;
– 2 weeks after 2nd dose;
– 4 weeks after 2nd dose (Timepoints 1, 2 and 3, respectively).
Finally, levels of IgG antibodies against the spike protein (S1 subunit) were determined for each sample (Architect, Abbott®).
Objectives of the Study:
Principal Objective: To analyze the levels of specific SARS-CoV-2 antibodies in breast milk of mRNA-vaccinated women across time and their correlation with serum antibody levels.
More about this Study:
Scientific Context: At the beginning of the vaccination campaign in the Parc Sanitari Sant Joan de Déu, multiple healthcare professionals who were breastfeeding consulted the Infectious Disease Department, concerned about vaccination against COVID. Their main concern was whether breastfeeding was a contraindication to vaccination and, therefore, they felt they had to choose between being vaccinated or ending breastfeeding, since they were considered at high risk of infection. Although pregnant and lactating women have not been included in the clinical trials for the approval of these vaccines, the main official bodies and scientific associations consider mRNA vaccines as low risk for lactation and, therefore, they recommend its administration in cases where the risk of contracting the disease may be higher than the potential risks of vaccination.
Recent studies have shown that milk produced by infected mothers is a source of anti-SARS-CoV-2 antibodies, and two reports have demonstrated the existence of anti-SARS-CoV-2 antibodies in women vaccinated with Moderna® and Pfizer-BioNTech® mRNA vaccines. If this exerts a protective effect for breastfed infants remains to be established.
Other Studies about Obstetrics:
MOOD-COVID aims to study the impact of the pandemic on the mental health of pregnant women, young mothers and their children.
This multinational study shows that women with COVID are 50% more likely to have complications during pregnancy, but if COVID is asymptomatic the risk is the same as if they did not have the infection.
What is the impact of COVID-19 in mothers and fetuses? This study aims to answer this question through an online survey to pregnant women with and without COVID-19
This international study aims to determine the clinical spectrum and the impact of SARS-CoV-2 infection during pregnancy.
Should breastfeeding women take care of the vertical transmission of SARS-CoV-2? Let’s study the role of COVID-19 in lactation.
This study allows in-depth understanding of the transmission of the infection, as well as the immune response that occurs in pregnant mothers and the newborn population during COVID-19.
Can hydroxychloroquine (HCQ) safely prevent infection and severe complications in pregnant women? This study focues on prevent COVID-19 during pregnancy.